Moreover, Siddiqui et al. used NS8593 to demonstrate that TRPM7 inhibits the migration and invasion properties of microglial cells.177 TRPM7 is a negative regulator of the angiogenic process.61 It suggests that specific TRPM7 activators can target both vascularization and cancer progression. Here, TRPM7 is linked to cancer.